[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fnYC1BJ2DTf0J93MxqHQ-CIxvWww_gQzZMAVOYG0DGGo":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":43,"rows":50},"University Hospital Ostrava",[4],146,false,31,6,26611,3,128,[14,17,20,22,24,26,28,30],{"name":15,"count":16},"Sepsis",7,{"name":18,"count":19},"Multiple Sclerosis",4,{"name":21,"count":19},"Extraesophageal Reflux",{"name":23,"count":19},"Acute Kidney Injury",{"name":25,"count":19},"Septic Shock",{"name":27,"count":19},"Laryngopharyngeal Reflux",{"name":29,"count":11},"Lower Urinary Tract Symptoms",{"name":31,"count":11},"Coronary Artery Disease",[33,38],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT05776797","AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation","2028-12-31","Optimal medication treatment in patients with cardiac resynchronization therapy",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT07499037","Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO","2029-09","Low anticoagulation dose of argatroban and enoxaparin during ECMO",[44,45,46,47,48,49],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[51,78,96,120,152,170,188,206,224,242,269,287,313,339,357,382,411,429,447,473,491,515,540,566,596,621,646,670,696,722],{"intervention":42,"totalTrials":52,"cells":53},1,{"EARLY_PHASE1":54,"PHASE1":57,"PHASE2":59,"PHASE3":72,"PHASE4":74,"NA":76},{"trials":55,"activeCount":56},[],0,{"trials":58,"activeCount":56},[],{"trials":60,"activeCount":52,"soonestReadout":41},[61],{"nctId":39,"briefTitle":40,"status":62,"phases":63,"primaryCompletion":41,"completion":64,"start":65,"enrollment":66,"conditions":67,"interventions":70},"NOT_YET_RECRUITING",[46],"2029-12","2027-01",200,[68,69],"Pneumonia","Heart Failure",[42,71],"Standard anticoagulation dose of argatroban and enoxaparin during ECMO",{"trials":73,"activeCount":56},[],{"trials":75,"activeCount":56},[],{"trials":77,"activeCount":56},[],{"intervention":71,"totalTrials":52,"cells":79},{"EARLY_PHASE1":80,"PHASE1":82,"PHASE2":84,"PHASE3":90,"PHASE4":92,"NA":94},{"trials":81,"activeCount":56},[],{"trials":83,"activeCount":56},[],{"trials":85,"activeCount":52,"soonestReadout":41},[86],{"nctId":39,"briefTitle":40,"status":62,"phases":87,"primaryCompletion":41,"completion":64,"start":65,"enrollment":66,"conditions":88,"interventions":89},[46],[68,69],[42,71],{"trials":91,"activeCount":56},[],{"trials":93,"activeCount":56},[],{"trials":95,"activeCount":56},[],{"intervention":37,"totalTrials":52,"cells":97},{"EARLY_PHASE1":98,"PHASE1":100,"PHASE2":102,"PHASE3":104,"PHASE4":106,"NA":108},{"trials":99,"activeCount":56},[],{"trials":101,"activeCount":56},[],{"trials":103,"activeCount":56},[],{"trials":105,"activeCount":56},[],{"trials":107,"activeCount":56},[],{"trials":109,"activeCount":52,"soonestReadout":36},[110],{"nctId":34,"briefTitle":35,"status":111,"phases":112,"primaryCompletion":36,"completion":113,"start":114,"enrollment":115,"conditions":116,"interventions":119},"RECRUITING",[49],"2029-03-31","2023-04-01",480,[117,118],"Recurrent Atrial Fibrillation","Persistent Atrial Fibrillation",[37],{"intervention":121,"totalTrials":52,"cells":122},"Nebivolol",{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":131,"NA":150},{"trials":124,"activeCount":56},[],{"trials":126,"activeCount":56},[],{"trials":128,"activeCount":56},[],{"trials":130,"activeCount":56},[],{"trials":132,"activeCount":56},[133],{"nctId":134,"briefTitle":135,"status":136,"phases":137,"primaryCompletion":138,"completion":138,"start":139,"enrollment":140,"conditions":141,"interventions":144},"NCT06035978","Determination of Drug Levels for Pharmacotherapy of Heart Failure","UNKNOWN",[48],"2026-04","2024-03",100,[142,143],"Cardiovascular Diseases","Heart Failure With Reduced Ejection Fraction",[121,145,146,147,148,149],"Valsartan and Sacubitril","Carvedilol","Bisoprolol","Metoprolol","Spironolactone",{"trials":151,"activeCount":56},[],{"intervention":145,"totalTrials":52,"cells":153},{"EARLY_PHASE1":154,"PHASE1":156,"PHASE2":158,"PHASE3":160,"PHASE4":162,"NA":168},{"trials":155,"activeCount":56},[],{"trials":157,"activeCount":56},[],{"trials":159,"activeCount":56},[],{"trials":161,"activeCount":56},[],{"trials":163,"activeCount":56},[164],{"nctId":134,"briefTitle":135,"status":136,"phases":165,"primaryCompletion":138,"completion":138,"start":139,"enrollment":140,"conditions":166,"interventions":167},[48],[142,143],[121,145,146,147,148,149],{"trials":169,"activeCount":56},[],{"intervention":146,"totalTrials":52,"cells":171},{"EARLY_PHASE1":172,"PHASE1":174,"PHASE2":176,"PHASE3":178,"PHASE4":180,"NA":186},{"trials":173,"activeCount":56},[],{"trials":175,"activeCount":56},[],{"trials":177,"activeCount":56},[],{"trials":179,"activeCount":56},[],{"trials":181,"activeCount":56},[182],{"nctId":134,"briefTitle":135,"status":136,"phases":183,"primaryCompletion":138,"completion":138,"start":139,"enrollment":140,"conditions":184,"interventions":185},[48],[142,143],[121,145,146,147,148,149],{"trials":187,"activeCount":56},[],{"intervention":147,"totalTrials":52,"cells":189},{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":194,"PHASE3":196,"PHASE4":198,"NA":204},{"trials":191,"activeCount":56},[],{"trials":193,"activeCount":56},[],{"trials":195,"activeCount":56},[],{"trials":197,"activeCount":56},[],{"trials":199,"activeCount":56},[200],{"nctId":134,"briefTitle":135,"status":136,"phases":201,"primaryCompletion":138,"completion":138,"start":139,"enrollment":140,"conditions":202,"interventions":203},[48],[142,143],[121,145,146,147,148,149],{"trials":205,"activeCount":56},[],{"intervention":148,"totalTrials":52,"cells":207},{"EARLY_PHASE1":208,"PHASE1":210,"PHASE2":212,"PHASE3":214,"PHASE4":216,"NA":222},{"trials":209,"activeCount":56},[],{"trials":211,"activeCount":56},[],{"trials":213,"activeCount":56},[],{"trials":215,"activeCount":56},[],{"trials":217,"activeCount":56},[218],{"nctId":134,"briefTitle":135,"status":136,"phases":219,"primaryCompletion":138,"completion":138,"start":139,"enrollment":140,"conditions":220,"interventions":221},[48],[142,143],[121,145,146,147,148,149],{"trials":223,"activeCount":56},[],{"intervention":149,"totalTrials":52,"cells":225},{"EARLY_PHASE1":226,"PHASE1":228,"PHASE2":230,"PHASE3":232,"PHASE4":234,"NA":240},{"trials":227,"activeCount":56},[],{"trials":229,"activeCount":56},[],{"trials":231,"activeCount":56},[],{"trials":233,"activeCount":56},[],{"trials":235,"activeCount":56},[236],{"nctId":134,"briefTitle":135,"status":136,"phases":237,"primaryCompletion":138,"completion":138,"start":139,"enrollment":140,"conditions":238,"interventions":239},[48],[142,143],[121,145,146,147,148,149],{"trials":241,"activeCount":56},[],{"intervention":243,"totalTrials":52,"cells":244},"Intrathecal morphine administration",{"EARLY_PHASE1":245,"PHASE1":247,"PHASE2":249,"PHASE3":251,"PHASE4":253,"NA":267},{"trials":246,"activeCount":56},[],{"trials":248,"activeCount":56},[],{"trials":250,"activeCount":56},[],{"trials":252,"activeCount":56},[],{"trials":254,"activeCount":56},[255],{"nctId":256,"briefTitle":257,"status":258,"phases":259,"primaryCompletion":260,"completion":260,"start":261,"enrollment":262,"conditions":263,"interventions":265},"NCT05920642","Postoperative Pain Relieve for Patients Undergoing Surgical Treatment of Femoral Fracture","COMPLETED",[48],"2025-07-29","2023-09-04",82,[264],"Proximal Femur Fracture",[243,266],"Parenteral administration of analgesics",{"trials":268,"activeCount":56},[],{"intervention":266,"totalTrials":52,"cells":270},{"EARLY_PHASE1":271,"PHASE1":273,"PHASE2":275,"PHASE3":277,"PHASE4":279,"NA":285},{"trials":272,"activeCount":56},[],{"trials":274,"activeCount":56},[],{"trials":276,"activeCount":56},[],{"trials":278,"activeCount":56},[],{"trials":280,"activeCount":56},[281],{"nctId":256,"briefTitle":257,"status":258,"phases":282,"primaryCompletion":260,"completion":260,"start":261,"enrollment":262,"conditions":283,"interventions":284},[48],[264],[243,266],{"trials":286,"activeCount":56},[],{"intervention":288,"totalTrials":52,"cells":289},"Aspirin 200mg qd, Clopidogrel 2x75mg qd",{"EARLY_PHASE1":290,"PHASE1":292,"PHASE2":294,"PHASE3":296,"PHASE4":298,"NA":311},{"trials":291,"activeCount":56},[],{"trials":293,"activeCount":56},[],{"trials":295,"activeCount":56},[],{"trials":297,"activeCount":56},[],{"trials":299,"activeCount":56},[300],{"nctId":301,"briefTitle":302,"status":258,"phases":303,"primaryCompletion":304,"completion":305,"start":306,"enrollment":307,"conditions":308,"interventions":310},"NCT01381185","REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction",[48],"2015-06","2015-07","2011-05",154,[309],"Acute Myocardial Infarction",[288],{"trials":312,"activeCount":56},[],{"intervention":314,"totalTrials":52,"cells":315},"Actilyse",{"EARLY_PHASE1":316,"PHASE1":318,"PHASE2":320,"PHASE3":322,"PHASE4":324,"NA":337},{"trials":317,"activeCount":56},[],{"trials":319,"activeCount":56},[],{"trials":321,"activeCount":56},[],{"trials":323,"activeCount":56},[],{"trials":325,"activeCount":56},[326],{"nctId":327,"briefTitle":328,"status":258,"phases":329,"primaryCompletion":330,"completion":331,"start":332,"enrollment":140,"conditions":333,"interventions":335},"NCT02132689","Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism",[48],"2015-05","2015-12","2011-03",[334],"Pulmonary Embolism",[314,336],"Heparine",{"trials":338,"activeCount":56},[],{"intervention":336,"totalTrials":52,"cells":340},{"EARLY_PHASE1":341,"PHASE1":343,"PHASE2":345,"PHASE3":347,"PHASE4":349,"NA":355},{"trials":342,"activeCount":56},[],{"trials":344,"activeCount":56},[],{"trials":346,"activeCount":56},[],{"trials":348,"activeCount":56},[],{"trials":350,"activeCount":56},[351],{"nctId":327,"briefTitle":328,"status":258,"phases":352,"primaryCompletion":330,"completion":331,"start":332,"enrollment":140,"conditions":353,"interventions":354},[48],[334],[314,336],{"trials":356,"activeCount":56},[],{"intervention":358,"totalTrials":52,"cells":359},"IMUNOR",{"EARLY_PHASE1":360,"PHASE1":362,"PHASE2":364,"PHASE3":366,"PHASE4":368,"NA":380},{"trials":361,"activeCount":56},[],{"trials":363,"activeCount":56},[],{"trials":365,"activeCount":56},[],{"trials":367,"activeCount":56},[],{"trials":369,"activeCount":56},[370],{"nctId":371,"briefTitle":372,"status":258,"phases":373,"primaryCompletion":374,"completion":374,"start":375,"enrollment":376,"conditions":377,"interventions":379},"NCT04710381","IMUNOR® Preparation in the Prevention of COVID-19",[48],"2021-06-02","2021-02-01",56,[378],"Covid19",[358],{"trials":381,"activeCount":56},[],{"intervention":383,"totalTrials":52,"cells":384},"Group A: Intramuscular",{"EARLY_PHASE1":385,"PHASE1":387,"PHASE2":389,"PHASE3":391,"PHASE4":407,"NA":409},{"trials":386,"activeCount":56},[],{"trials":388,"activeCount":56},[],{"trials":390,"activeCount":56},[],{"trials":392,"activeCount":56},[393],{"nctId":394,"briefTitle":395,"status":258,"phases":396,"primaryCompletion":397,"completion":398,"start":399,"enrollment":400,"conditions":401,"interventions":404},"NCT01818310","Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia",[46,47],"2018-09","2018-10","2012-09",80,[402,403],"Critical Lower Limb Ischemia","Type-2 Diabetes Mellitus",[383,405,406],"Group B: Intraarterial","Group C: Intravenous",{"trials":408,"activeCount":56},[],{"trials":410,"activeCount":56},[],{"intervention":405,"totalTrials":52,"cells":412},{"EARLY_PHASE1":413,"PHASE1":415,"PHASE2":417,"PHASE3":419,"PHASE4":425,"NA":427},{"trials":414,"activeCount":56},[],{"trials":416,"activeCount":56},[],{"trials":418,"activeCount":56},[],{"trials":420,"activeCount":56},[421],{"nctId":394,"briefTitle":395,"status":258,"phases":422,"primaryCompletion":397,"completion":398,"start":399,"enrollment":400,"conditions":423,"interventions":424},[46,47],[402,403],[383,405,406],{"trials":426,"activeCount":56},[],{"trials":428,"activeCount":56},[],{"intervention":406,"totalTrials":52,"cells":430},{"EARLY_PHASE1":431,"PHASE1":433,"PHASE2":435,"PHASE3":437,"PHASE4":443,"NA":445},{"trials":432,"activeCount":56},[],{"trials":434,"activeCount":56},[],{"trials":436,"activeCount":56},[],{"trials":438,"activeCount":56},[439],{"nctId":394,"briefTitle":395,"status":258,"phases":440,"primaryCompletion":397,"completion":398,"start":399,"enrollment":400,"conditions":441,"interventions":442},[46,47],[402,403],[383,405,406],{"trials":444,"activeCount":56},[],{"trials":446,"activeCount":56},[],{"intervention":448,"totalTrials":52,"cells":449},"sirolimus-eluting balloon (SEB) MagicTouch",{"EARLY_PHASE1":450,"PHASE1":452,"PHASE2":454,"PHASE3":456,"PHASE4":469,"NA":471},{"trials":451,"activeCount":56},[],{"trials":453,"activeCount":56},[],{"trials":455,"activeCount":56},[],{"trials":457,"activeCount":56},[458],{"nctId":459,"briefTitle":460,"status":258,"phases":461,"primaryCompletion":462,"completion":463,"start":464,"enrollment":66,"conditions":465,"interventions":467},"NCT03667313","Treatment of In-Stent Restenosis 2 Study",[47],"2021-11-30","2021-12-31","2018-10-01",[466],"Coronary Restenosis",[448,468],"paclitaxel-eluting balloon (PEB) Sequent Please",{"trials":470,"activeCount":56},[],{"trials":472,"activeCount":56},[],{"intervention":468,"totalTrials":52,"cells":474},{"EARLY_PHASE1":475,"PHASE1":477,"PHASE2":479,"PHASE3":481,"PHASE4":487,"NA":489},{"trials":476,"activeCount":56},[],{"trials":478,"activeCount":56},[],{"trials":480,"activeCount":56},[],{"trials":482,"activeCount":56},[483],{"nctId":459,"briefTitle":460,"status":258,"phases":484,"primaryCompletion":462,"completion":463,"start":464,"enrollment":66,"conditions":485,"interventions":486},[47],[466],[448,468],{"trials":488,"activeCount":56},[],{"trials":490,"activeCount":56},[],{"intervention":492,"totalTrials":52,"cells":493},"BMAC",{"EARLY_PHASE1":494,"PHASE1":496,"PHASE2":498,"PHASE3":509,"PHASE4":511,"NA":513},{"trials":495,"activeCount":56},[],{"trials":497,"activeCount":56},[],{"trials":499,"activeCount":56},[500],{"nctId":501,"briefTitle":502,"status":258,"phases":503,"primaryCompletion":504,"completion":463,"start":505,"enrollment":506,"conditions":507,"interventions":508},"NCT03372954","Retrograde Application of Bone Marrow Aspirate Concentrate",[46],"2020-12-31","2018-01-01",40,[69],[492],{"trials":510,"activeCount":56},[],{"trials":512,"activeCount":56},[],{"trials":514,"activeCount":56},[],{"intervention":516,"totalTrials":52,"cells":517},"Intravenous Vancomycin administration",{"EARLY_PHASE1":518,"PHASE1":520,"PHASE2":522,"PHASE3":524,"PHASE4":526,"NA":528},{"trials":519,"activeCount":56},[],{"trials":521,"activeCount":56},[],{"trials":523,"activeCount":56},[],{"trials":525,"activeCount":56},[],{"trials":527,"activeCount":56},[],{"trials":529,"activeCount":56},[530],{"nctId":531,"briefTitle":532,"status":258,"phases":533,"primaryCompletion":534,"completion":534,"start":535,"enrollment":536,"conditions":537,"interventions":539},"NCT06506032","Vancomycin and Negative Pressure Therapy for Post-sternotomy Deep Sternal Wound Infection",[],"2023-12-31","2021-07-30",10,[538],"Post-Sternotomy Deep Sternal Wound Infection",[516],{"intervention":541,"totalTrials":52,"cells":542},"Vitamin D3 + anabolic substance",{"EARLY_PHASE1":543,"PHASE1":545,"PHASE2":547,"PHASE3":549,"PHASE4":551,"NA":553},{"trials":544,"activeCount":56},[],{"trials":546,"activeCount":56},[],{"trials":548,"activeCount":56},[],{"trials":550,"activeCount":56},[],{"trials":552,"activeCount":56},[],{"trials":554,"activeCount":56},[555],{"nctId":556,"briefTitle":557,"status":258,"phases":558,"primaryCompletion":559,"completion":560,"start":561,"enrollment":562,"conditions":563,"interventions":565},"NCT03588767","Endocrine Response of the Organism to Polytrauma",[49],"2020-05-30","2021-01-31","2017-05-31",60,[564],"Polytrauma",[541],{"intervention":567,"totalTrials":52,"cells":568},"Dexamethasone",{"EARLY_PHASE1":569,"PHASE1":571,"PHASE2":573,"PHASE3":575,"PHASE4":577,"NA":579},{"trials":570,"activeCount":56},[],{"trials":572,"activeCount":56},[],{"trials":574,"activeCount":56},[],{"trials":576,"activeCount":56},[],{"trials":578,"activeCount":56},[],{"trials":580,"activeCount":56},[581],{"nctId":582,"briefTitle":583,"status":258,"phases":584,"primaryCompletion":585,"completion":586,"start":587,"enrollment":66,"conditions":588,"interventions":595},"NCT03398044","Administration of Dexamethasone in PONV Prophylaxis in Children Undergoing Adenotomy",[49],"2018-12-31","2019-03-31","2017-01-01",[589,590,591,592,593,594],"Nasal Obstruction","Nasopharyngeal Obstruction","Snoring","Apnea, Obstructive","Hearing Loss","Otitis",[567],{"intervention":597,"totalTrials":52,"cells":598},"Ibuprofen administration",{"EARLY_PHASE1":599,"PHASE1":601,"PHASE2":603,"PHASE3":605,"PHASE4":607,"NA":609},{"trials":600,"activeCount":56},[],{"trials":602,"activeCount":56},[],{"trials":604,"activeCount":56},[],{"trials":606,"activeCount":56},[],{"trials":608,"activeCount":56},[],{"trials":610,"activeCount":56},[611],{"nctId":612,"briefTitle":613,"status":258,"phases":614,"primaryCompletion":615,"completion":586,"start":616,"enrollment":617,"conditions":618,"interventions":620},"NCT04227652","Control of Fever in Septic Patients",[49],"2019-02-28","2013-09-03",140,[15,619,25],"Severe Sepsis",[597],{"intervention":622,"totalTrials":52,"cells":623},"Nicotine patch",{"EARLY_PHASE1":624,"PHASE1":626,"PHASE2":628,"PHASE3":630,"PHASE4":632,"NA":634},{"trials":625,"activeCount":56},[],{"trials":627,"activeCount":56},[],{"trials":629,"activeCount":56},[],{"trials":631,"activeCount":56},[],{"trials":633,"activeCount":56},[],{"trials":635,"activeCount":56},[636],{"nctId":637,"briefTitle":638,"status":258,"phases":639,"primaryCompletion":560,"completion":640,"start":641,"enrollment":642,"conditions":643,"interventions":645},"NCT03847155","Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery",[49],"2021-02-08","2015-09-23",52,[644],"Nicotine Dependence",[622],{"intervention":647,"totalTrials":52,"cells":648},"Ginkgo Biloba Extract",{"EARLY_PHASE1":649,"PHASE1":651,"PHASE2":653,"PHASE3":655,"PHASE4":657,"NA":659},{"trials":650,"activeCount":56},[],{"trials":652,"activeCount":56},[],{"trials":654,"activeCount":56},[],{"trials":656,"activeCount":56},[],{"trials":658,"activeCount":56},[],{"trials":660,"activeCount":56},[661],{"nctId":662,"briefTitle":663,"status":258,"phases":664,"primaryCompletion":665,"completion":665,"start":666,"enrollment":506,"conditions":667,"interventions":669},"NCT03425045","Repetitive Transcranial Magnetic Stimulation for Chronic Subjective Tinnitus",[49],"2018-03-31","2015-03-01",[668],"Tinnitus, Subjective",[647],{"intervention":671,"totalTrials":52,"cells":672},"Anaesthetics",{"EARLY_PHASE1":673,"PHASE1":675,"PHASE2":677,"PHASE3":679,"PHASE4":681,"NA":683},{"trials":674,"activeCount":56},[],{"trials":676,"activeCount":56},[],{"trials":678,"activeCount":56},[],{"trials":680,"activeCount":56},[],{"trials":682,"activeCount":56},[],{"trials":684,"activeCount":56},[685],{"nctId":686,"briefTitle":687,"status":258,"phases":688,"primaryCompletion":689,"completion":690,"start":304,"enrollment":691,"conditions":692,"interventions":695},"NCT02664142","BIS Monitoring of the Depth of Anaesthesia in Children",[49],"2017-09","2017-11",220,[693,694],"General Surgery","Anaesthesia",[671],{"intervention":697,"totalTrials":52,"cells":698},"Argatroban",{"EARLY_PHASE1":699,"PHASE1":701,"PHASE2":703,"PHASE3":705,"PHASE4":707,"NA":709},{"trials":700,"activeCount":56},[],{"trials":702,"activeCount":56},[],{"trials":704,"activeCount":56},[],{"trials":706,"activeCount":56},[],{"trials":708,"activeCount":56},[],{"trials":710,"activeCount":56},[711],{"nctId":712,"briefTitle":713,"status":258,"phases":714,"primaryCompletion":715,"completion":534,"start":716,"enrollment":140,"conditions":717,"interventions":720},"NCT06038682","Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure",[],"2023-07-31","2020-04-01",[718,719],"ARDS","COVID-19",[697,721],"Heparin",{"intervention":721,"totalTrials":52,"cells":723},{"EARLY_PHASE1":724,"PHASE1":726,"PHASE2":728,"PHASE3":730,"PHASE4":732,"NA":734},{"trials":725,"activeCount":56},[],{"trials":727,"activeCount":56},[],{"trials":729,"activeCount":56},[],{"trials":731,"activeCount":56},[],{"trials":733,"activeCount":56},[],{"trials":735,"activeCount":56},[736],{"nctId":712,"briefTitle":713,"status":258,"phases":737,"primaryCompletion":715,"completion":534,"start":716,"enrollment":140,"conditions":738,"interventions":739},[],[718,719],[697,721]]